WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.87 CNY | +0.41% |
|
-1.22% | -23.91% |
| 05-20 | Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
| 05-08 | US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD. | Generic Pharmaceuticals | +0.41% | -1.22% | -23.91% | -37.00% | -50.66% | 411M |  |  | |
